Peter van Balen

900 citations
36 papers · 555 · h-index 13

Impact in

Papers in

  • Hematology 19
    • Hematopoietic Stem Cell Transplantation 15
    • Acute Myeloid Leukemia Research 5
  • Immunology 17
    • T-cell and B-cell Immunology 13
    • Immunotherapy and Immune Responses 10
    • Immune Cell Function and Interaction 8
Co-authors
J.H. Frederik Falkenburg (21 shared papers)Inge Jedema (14 shared papers)Michel G.D. Kester (7 shared papers)Constantijn J.M. Halkes (16 shared papers)Hendrik Veelken (14 shared papers)Marieke Griffioen (7 shared papers)Olaf L. Cremer (1 shared paper)Cor J. Kalkman (1 shared paper)
Journals
Frontiers in Immunology (7 papers)Blood (6 papers)Annals of Hematology (2 papers)Leukemia (2 papers)The Journal of Immunology (2 papers)
Partner nations
NetherlandsGermanyUnited States

In The Last Decade

Peter van Balen

33 papers receiving 540 citations

Peers

Peter van Balen
Comparison fields: 5 of 62
  • Hematology 175
  • Internal Medicine 49
  • Immunology 241
  • Transplantation 20
  • Oncology 113
Replace Carolina Martínez‐Laperche with:
Carolina Martínez‐Laperche Spain
Tomasz Rozmysłowicz United States
Carlos Bravo‐Pérez Spain
Галина Новичкова Russia
Istvan Redei United States
Linda Berberian United States
F. T. Cordingley United Kingdom
Femke Stephan Netherlands
Ann Van de Velde Belgium
Sandra Grässle Germany
Peter van Balen relative to Carolina Martínez‐Laperche Spain Carolina Martínez‐Laperche's profile →
Citations per field
00.5×5×10×15×20×24.5×
Carolina Martínez‐Laperche · 1×
Citations per year

Countries citing papers authored by Peter van Balen

Since Specialization
Citations

This map shows the geographic impact of Peter van Balen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter van Balen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter van Balen more than expected).

Fields of papers citing papers by Peter van Balen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter van Balen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter van Balen. The network helps show where Peter van Balen may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter van Balen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter van Balen Line = papers co-authored together Peter van Balen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response
Journal of Clinical Investigation ·Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs, Liesbeth C. de Wreede, Matthijs Eefting, Peter A. von dem Borne, Peter van Balen, Mirjam H.M. Heemskerk, Arend Mulder, F. Claas, Marcelo A. Navarrete, Wilhelmina M. Honders, Caroline E. Rutten, Hendrik Veelken, Inge Jedema, Constantijn J.M. Halkes, Marieke Griffioen, J.H. Frederik Falkenburg
201777
2
Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning
Science Advances ·Jonas Birkelund Nilsson, Saghar Kaabinejadian, Hooman Yari, Michel G.D. Kester, Peter van Balen, William H. Hildebrand, Morten Nielsen
202365
3
Predictors of the post‐thrombotic syndrome with non‐invasive venous examinations in patients 6 weeks after a first episode of deep vein thrombosis
Journal of Thrombosis and Haemostasis ·Lidwine W. Tick, Carine J.M. Doggen, Frits R. Rosendaal, Wladimir Faber, M.T. Bousema, A. J. C. Mackaay, Peter van Balen, Mark H.H. Kramer
201058
4
Prognosis Following Severe Head Injury: Development and Validation of a Model for Prediction of Death, Disability, and Functional Recovery
The Journal of Trauma: Injury, Infection, and Critical Care ·Olaf L. Cremer, Karel G.M. Moons, Gert W. van Dijk, Peter van Balen, Cor J. Kalkman
200651
5
Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM
Blood ·Thuja Meurer, Pietro Crivello, M. Metzing, Michel G.D. Kester, Dominik A. Megger, Weiqiang Chen, Peter A. van Veelen, Peter van Balen, Astrid M. Westendorf, Georg Homa, Sophia E. Layer, Amin T. Turki, Marieke Griffioen, Péter Horn, Barbara Sitek, Dietrich W. Beelen, J.H. Frederik Falkenburg, Esteban Arrieta‐Bolaños, Katharina Fleischhauer
202033
6
HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study
Frontiers in Immunology ·Peter van Balen, Inge Jedema, Marleen M. van Loenen, Renate de Boer, H.M. van Egmond, Renate S. Hagedoorn, Conny Hoogstaten, Sabrina A.J. Veld, Lois Hageman, P. A. G. van Liempt, Jaap Jan Zwaginga, Pauline Meij, Hendrik Veelken, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk
202031
7
Oncogene expression during progression of mouse mammary tumor cells; activity of a proviral enhancer and the resulting expression of int‐2 is influenced by the state of differentiation.
The EMBO Journal ·Arnoud Sonnenberg, Peter van Balen, J. Hilgers, Ed Schuuring, Roel Nusse
198728
8
CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II
Frontiers in Immunology ·Peter van Balen, Cornelis A.M. van Bergen, Simone A.P. van Luxemburg-Heijs, Wendy de Klerk, Esther H.M. van Egmond, Sabrina A.J. Veld, Constantijn J.M. Halkes, Jaap Jan Zwaginga, Marieke Griffioen, Inge Jedema, J.H. Frederik Falkenburg
201827
9
Immunopeptidome Analysis of HLA-DPB1 Allelic Variants Reveals New Functional Hierarchies
The Journal of Immunology ·Peter van Balen, Michel G.D. Kester, Wendy de Klerk, Pietro Crivello, Esteban Arrieta‐Bolaños, Arnoud H. de Ru, Inge Jedema, Yassene Mohammed, Mirjam H.M. Heemskerk, Katharina Fleischhauer, Peter A. van Veelen, J.H. Frederik Falkenburg
202026
10
Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation—a phase I/II study
Leukemia ·Marthe C.J. Roex, Peter van Balen, Lothar Germeroth, Lois Hageman, Esther van Egmond, Sabrina A.J. Veld, Conny Hoogstraten, Ellis van Liempt, Jaap Jan Zwaginga, Liesbeth C. de Wreede, Pauline Meij, Ann C.T.M. Vossen, Sophia Danhof, Hermann Einsele, M. Ron Schaafsma, Hendrik Veelken, Constantijn J.M. Halkes, Inge Jedema, J.H. Frederik Falkenburg
201919
11
Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation
Frontiers in Immunology ·Thuja Meurer, Esteban Arrieta‐Bolaños, M. Metzing, Mona‐May Langer, Peter van Balen, J.H. Frederik Falkenburg, Dietrich W. Beelen, Peter A. Horn, Katharina Fleischhauer, Pietro Crivello
201819
12
Human T cells recognize HLA-DP–bound peptides in two orientations
Proceedings of the National Academy of Sciences ·Sebastian Klobuch, Jia Jia Lim, Peter van Balen, Michel G.D. Kester, Wendy de Klerk, Arnoud H. de Ru, Cilia R. Pothast, Inge Jedema, Jan W. Drijfhout, Jamie Rossjohn, Hugh H. Reid, Peter A. van Veelen, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk
202214
13
Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses
Leukemia ·Jeppe F. Severens, Emin Onur Karakaslar, Bert A. van der Reijden, Elena Sánchez‐López, Redmar R. van den Berg, Constantijn J.M. Halkes, Peter van Balen, Hendrik Veelken, Marcel Reinders, Marieke Griffioen, Erik B. van den Akker
202412
14
Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity
Frontiers in Immunology ·Aicha Laghmouchi, Michel G.D. Kester, Conny Hoogstraten, Lois Hageman, Wendy de Klerk, Wesley Huisman, Eva A. S. Koster, Arnoud H. de Ru, Peter van Balen, Sebastian Klobuch, Peter A. van Veelen, J.H. Frederik Falkenburg, Inge Jedema
202211
15
Monoclonal antibodies detecting different epitopes on the Forssman glycolipid hapten.
The Journal of Immunology ·Arnoud Sonnenberg, Peter van Balen, Trudi Hengeveld, Geert J.C.M. Kolvenbag, R.P. Van Hoeven, J. Hilgers
19869
16
A transcriptomic based deconvolution framework for assessing differentiation stages and drug responses of AML
npj Precision Oncology ·Emin Onur Karakaslar, Jeppe F. Severens, Elena Sánchez‐López, Peter A. van Veelen, Mihaela Zlei, Jacques J. M. van Dongen, Annemarie M. Otte, Constantijn J.M. Halkes, Peter van Balen, Hendrik Veelken, Marcel Reinders, Marieke Griffioen, Erik B. van den Akker
20248
17
The allogeneic HLA-DP-restricted T-cell repertoire provoked by allogeneic dendritic cells contains T cells that show restricted recognition of hematopoietic cells including primary malignant cells
Haematologica ·Aicha Laghmouchi, Conny Hoogstraten, Peter van Balen, J.H. Frederik Falkenburg, Inge Jedema
20188
18
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens
Blood ·Kyra J. Fuchs, Marian van de Meent, M. Willy Honders, Indu Khatri, Michel G.D. Kester, Eva A. S. Koster, Georgia Koutsoumpli, Arnoud H. de Ru, Cornelis A.M. van Bergen, Peter A. van Veelen, Peter A.C. ’t Hoen, Peter van Balen, Erik B. van den Akker, Hendrik Veelken, Constantijn J.M. Halkes, J.H. Frederik Falkenburg, Marieke Griffioen
20247
19
Alloreactive T Cell Receptor Diversity against Structurally Similar or Dissimilar HLA-DP Antigens Assessed by Deep Sequencing
Frontiers in Immunology ·Esteban Arrieta‐Bolaños, Pietro Crivello, M. Metzing, Thuja Meurer, Müberra Ahci, Julie Rytlewski, Marissa Vignali, Erik Yusko, Peter van Balen, Peter A. Horn, J.H. Frederik Falkenburg, Katharina Fleischhauer
20187
20
Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction
Frontiers in Immunology ·Peter van Balen, Boris van der Zouwen, Alwine B. Kruisselbrink, Matthijs Eefting, Károly Szuhai, Ekaterina S. Jordanova, J.H. Frederik Falkenburg, Inge Jedema
20187

About Peter van Balen

Peter van Balen is a scholar working on Hematology, Immunology, Genetics, Molecular Biology and Epidemiology, having authored 36 papers that have together received 555 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (15 papers), T-cell and B-cell Immunology (13 papers), Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (8 papers), Virus-based gene therapy research (7 papers), Cytomegalovirus and herpesvirus research (6 papers), Acute Myeloid Leukemia Research (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). The work is most often cited by research in Hematology (175 citations), Internal Medicine (49 citations), Immunology (241 citations), Transplantation (20 citations) and Oncology (113 citations). Peter van Balen has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include J.H. Frederik Falkenburg, Inge Jedema, Michel G.D. Kester, Constantijn J.M. Halkes, Hendrik Veelken, Marieke Griffioen, Olaf L. Cremer, Cor J. Kalkman, Karel G.M. Moons and Mirjam H.M. Heemskerk. Their work appears in journals such as Frontiers in Immunology, Blood, Annals of Hematology, Leukemia and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carolina Martínez‐LapercheBreakdown of academic impact, for papers by Tomasz RozmysłowiczBreakdown of academic impact, for papers by Carlos Bravo‐PérezBreakdown of academic impact, for papers by Галина НовичковаBreakdown of academic impact, for papers by Istvan RedeiBreakdown of academic impact, for papers by Linda BerberianBreakdown of academic impact, for papers by F. T. CordingleyBreakdown of academic impact, for papers by Femke StephanBreakdown of academic impact, for papers by Ann Van de VeldeBreakdown of academic impact, for papers by Sandra Grässle